They suggested that IL-6 is a valuable determinant in categorizing patients with intermediate atherosclerotic CVD risk.[32] In a recent study, Walter et al declared that IL-6 concentrations were significantly higher in functionally relevant CAD than in healthy controls. The gene discussed is IL6; the disease is coronary artery disorder.